Crinetics Pharmaceuticals Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Diego CA United States (2008)

Organization Overview

First Clinical Trial
2017
NCT03276858
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Crinetics Pharmaceuticals Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

Paltusotine (8 trials)

Drugs in Phase 2 Trials (1)

crn04894 (3 trials)

Drugs in Phase 1 Trials (2)

crn01941 (1 trial)

midazolam (versed) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acromegaly (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 12
  • # of Trial APIs: 4